Retraction
Analysis of the Clinical Efficacy of Azacytidine + Venetoclax in the Treatment of Elderly Patients with Relapsed Refractory Acute Myeloid Leukemia
Paper Information
Record ID:
62160
Author(s):
Publication Date:
October 14, 2022
Retraction Date:
October 04, 2023
(2.1 years years ago)
Subjects:
Broad Categories:
Medicine
Medicine
Institution:
Department of Hematology, Nanxishan Hospital of Guangxi Zhuang Autonomous Region, Guilin, Guangxi Province, ChinaCountry:
🇨🇳 ChinaArticle Type:
Publisher:
Hindawi
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
- Concerns/Issues About Data
- Concerns/Issues about Results and/or Conclusions
- Concerns/Issues about Referencing/Attributions
- Concerns/Issues with Peer Review
- Investigation by Journal/Publisher
- Investigation by Third Party
- Paper Mill
- Computer-Aided Content or Computer-Generated Content
- Unreliable Results and/or Conclusions
Nature of Retraction:
Retraction
Retraction Notice:
10.1155/2023/9840736Citations (6)
6
Total Citations4
Post-Retraction(66.7%)
1
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
2
Within 1 year
0
After 2+ years
570
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Meta-analysis on the effectiveness and safety of venetoclax-based combination therapy with hypomethylation in acute myeloid leukemia
Junqing Wang, Yingying Chen, Dongdong Ji et al. (9 authors)
European journal of medical research
Open Access
Published: Apr 2025
570 days after retraction
Comparative efficacy and safety in low-intensity treatment for acute myeloid leukemia in older patients: a systematic review and network meta-analysis
Wenze Li, Sijing Kang, Jiao Yu et al. (8 authors)
European journal of medical research
Open Access
Published: Apr 2025
559 days after retraction
Venetoclax adverse event monitoring: a safety meta-analysis of randomized controlled trials and a retrospective evaluation of the FAERS
Muhammed Favas, Maneesh Semwal, Beema T Yoosuf et al. (5 authors)
Annals of Hematology
Published: Feb 2024
4 citations
4 citations
145 days after retraction
Meta‑analysis of the efficacy of venetoclax and azacitidine combination therapy and azacitidine monotherapy for treating acute myeloid leukemia
Yuqin Xie, Xueqin Wei, Weiwei Wang et al. (6 authors)
Experimental and Therapeutic Medicine
Open Access
Published: Feb 2024
145 days after retraction
Retracted: Analysis of the Clinical Efficacy of Azacytidine + Venetoclax in the Treatment of Elderly Patients with Relapsed Refractory Acute Myeloid Leukemia
Evidence-Based Complementary and Alternative Medicine
Evidence-based Complementary and Alternative Medicine
Open Access
Published: Jan 2023
276 days before retraction
Quick Stats
Total Citations:
10
Years Since Retraction:
2.1 years
Open Access:
Yes
Last Checked:
Jul 24, 2025